Cryotherapy directed to the cancerous part of the prostate may be an effective and less invasive treatment option for men with intermediate-risk, unilateral prostate cancer, without the common side effects of traditional approaches, a small study suggests. The procedure was well tolerated, and 80% of the men were free of clinically significant disease at six and 18 months post-treatment, its researchers reported. Still, larger studies are needed to better assess the therapeutic potential of partial cryotherapy…
You must be logged in to read/download the full post.
The post Cryotherapy May Ably Treat Intermediate-risk Prostate Cancer appeared first on BioNewsFeeds.